These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 3796739
21. [Broncholytic effect of Atrovent in comparison with a combination preparation in obstructive lung diseases]. Holzhey P. Wien Med Wochenschr; 1975 Dec 05; 125(49):711-6. PubMed ID: 1229127 [No Abstract] [Full Text] [Related]
22. [Treatment of respiratory insufficiency in chronic nonspecific lung diseases]. Kazanbiev NK. Klin Med (Mosk); 1995 Dec 05; 73(4):24-7. PubMed ID: 7474811 [No Abstract] [Full Text] [Related]
24. Drugs and the elderly. Precautions in using bronchodilators. Todd B. Geriatr Nurs; 1984 Mar 05; 5(7):328-30. PubMed ID: 6565620 [No Abstract] [Full Text] [Related]
27. [Why is Etaphylline not better in chronic aspecific respiratory disease?]. Zuidema J, Merkus FW. Ned Tijdschr Geneeskd; 1979 Sep 01; 123(35):1527-8. PubMed ID: 492369 [No Abstract] [Full Text] [Related]
28. Bronchodilators and chronic obstructive pulmonary disease. Singh A. N Z Med J; 1997 Aug 08; 110(1049):300. PubMed ID: 9293287 [No Abstract] [Full Text] [Related]
29. [Eight parameters of ventilatory function in evaluating the therapeutic effects of bronchodilators]. Huang ZB. Zhonghua Yi Xue Za Zhi; 1984 Jan 08; 64(1):29-32. PubMed ID: 6430490 [No Abstract] [Full Text] [Related]
30. Effects of oral doxofylline on inflammatory changes and altered cell proliferation in chronic obstructive bronchitis. Cogo R, Castronuovo A. Eur Rev Med Pharmacol Sci; 2000 Jan 08; 4(1-2):15-20. PubMed ID: 11409184 [Abstract] [Full Text] [Related]
31. [Therapeutical effect of a new antidyspnoeic drug in the chronic obstructive pulmonary disease (author's transl)]. Chillón F. Folia Clin Int (Barc); 1973 Jun 08; 23(6):464-76. PubMed ID: 4805350 [No Abstract] [Full Text] [Related]
33. [Use of theophylline and proxyphylline in the treatment of obstructive lung diseases in children: demands for new dosage routines]. Holmen TL, Selvig K, Bjerve KS, Aas K, Rugstad HE. Tidsskr Nor Laegeforen; 1980 Jan 30; 100(3):172-73. PubMed ID: 7385142 [No Abstract] [Full Text] [Related]